Telehealth company Ro has a new spokesperson for its booming GLP-1 business: Serena Williams, the 23-time Grand Slam champion ...

Through innovation, cost discipline, legal action, and competitive pricing, Novo Nordisk has reasserted its leadership in the GLP-1 market. With a robust pipeline and global expansion, NVO is poised ...

Serena Williams has joined the growing number of people turning to GLP-1 medications as a weight-loss solution. The tennis ...

Serena Williams broke her silence about her weight loss journey, revealing she used medication to help her lose 31 pounds.

Williams has been making headlines lately for her significant weight loss transformation. And now she's opening up about it!

Dr Shazia Malik - a consultant obstetrician and gynaecologist for The Portland Hospital - discussed the pros and cons of ...

Serena Williams shared a bikini pic after losing 31 pounds with GLP-1 medication, reflecting on her health challenges and ...

A Comeback Fueled by Resilience Danish pharmaceutical giant Novo Nordisk (NYSE:NVO) has been a trailblazer in the GLP-1 drug ...

Tennis star Serena Williams' candor about her GLP-1 use may help dispel the pesky health inaccuracy that weight loss is a ...

Serena Williams opens up about losing over 31 pounds using GLP-1 medication, sharing how it enhanced her healthy lifestyle.

After years of struggling with postpartum weight gain despite strict training and healthy eating, the 23-time Grand Slam ...

Serena Williams has revealed she lost 31 pounds on the GLP-1 Zepbound: "I just couldn't get my weight to where I needed to be at a healthy place." ...